NeuBase Therapeutics 뉴스 - NBSE

기업명	주식 심볼	시장	주식 타입
NeuBase Therapeutics Inc	NBSE	나스닥	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	0.0051	1.26%	0.4101	05:30:00

개장가	저가	고가	종가	전일 종가
0.3766	0.36	0.418	0.4101	0.405

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
06/05/2024	20:30	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
06/04/2024	05:05	GLOBE	NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
08/03/2024	06:01	EDGAR2	Form 8-K - Current report
24/02/2024	06:01	EDGAR2	Form 8-K - Current report
26/01/2024	22:00	EDGAR2	Form 8-K - Current report
17/01/2024	20:15	EDGAR2	Form 8-K - Current report
28/12/2023	21:00	EDGAR2	Form 8-K - Current report
28/12/2023	20:15	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
22/12/2023	20:15	EDGAR2	Form 8-K - Current report
27/11/2023	23:00	GLOBE	Psychemedics Corporation Appoints Daniella Mehalik as VP -..
10/11/2023	06:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/2023	07:00	EDGAR2	Form 8-K - Current report
20/10/2023	20:30	EDGAR2	Form 8-K - Current report
18/10/2023	21:00	EDGAR2	Form 8-K - Current report
30/09/2023	05:10	EDGAR2	Form 8-K - Current report
21/09/2023	09:42	EDGAR2	Form 5 - Annual statement of changes in beneficial ownership..
21/09/2023	06:28	EDGAR2	Form SC 13D/A - General statement of acquisition of..
19/09/2023	05:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/09/2023	05:20	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
19/09/2023	05:17	EDGAR2	Form 8-K - Current report
14/09/2023	19:03	EDGAR2	Form SC 13D/A - General statement of acquisition of..
12/09/2023	06:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
08/09/2023	20:00	GLOBE	NeuBase Therapeutics Issues Statement Regarding Filing By..
08/09/2023	06:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
06/09/2023	23:00	PRNUS	SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
01/09/2023	00:50	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
15/08/2023	05:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/2023	19:18	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
11/08/2023	19:15	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/08/2023	06:13	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
05/08/2023	05:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
03/08/2023	20:05	EDGAR2	Form 8-K - Current report
02/08/2023	05:45	EDGAR2	Form PRE 14A - Other preliminary proxy statements
01/08/2023	05:10	EDGAR2	Form 8-K - Current report
28/07/2023	19:03	EDGAR2	Form S-1 - General form for registration of securities under..
01/07/2023	05:21	EDGAR2	Form 8-K - Current report
30/06/2023	21:42	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
30/06/2023	21:41	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

NBSE NeuBase Therapeutics Inc

최근 뉴스

NBSE 과거 데이터 - 1일

NBSE 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

NeuBase Therapeutics Inc (NBSE) 뉴스

NBSE NeuBase Therapeutics Inc

최근 뉴스

NBSE 과거 데이터 - 1일

NBSE 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기